We are live on ! Find out more
IART icon

Integra LifeSciences
IART

280 hedge funds and large institutions have $4.16B invested in Integra LifeSciences in 2019 Q3 according to their latest regulatory filings, with 42 funds opening new positions, 100 increasing their positions, 88 reducing their positions, and 23 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 23

50% more funds holding in top 10

Funds holding in top 10: 2 → 3 (+1)

29% more call options, than puts

Call options by funds: $5.85M | Put options by funds: $4.52M

14% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 88

7% more funds holding

Funds holding: 262 → 280 (+18)

5% more capital invested

Capital invested by funds: $3.95B → $4.16B (+$210M)

1.8% less ownership

Funds ownership: 82.73% → 80.93% (-1.8%)

Holders
280
Holders Change
+18
Holders Change %
+6.87%
% of All Funds
6.14%
Holding in Top 10
3
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+50%
% of All Funds
0.07%
New
42
Increased
100
Reduced
88
Closed
23
Calls
$5.85M
Puts
$4.52M
Net Calls
+$1.33M
Net Calls Change
+$1.21M

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$23.5M
2
Wellington Management Group
Wellington Management Group
Massachusetts
+$22.1M
3
Vanguard Group
Vanguard Group
Pennsylvania
+$21.1M
4
Brown Advisory
Brown Advisory
Maryland
+$13.9M
5
Millennium Management
Millennium Management
New York
+$12.6M

Top Sellers

1
Fidelity Investments
Fidelity Investments
Massachusetts
-$98.7M
2
Capital World Investors
Capital World Investors
California
-$63.5M
3
Capital International Investors
Capital International Investors
California
-$27.3M
4
Westfield Capital Management
Westfield Capital Management
Massachusetts
-$16.4M
5
State Street
State Street
Massachusetts
-$14.5M
Name Holding Trade Value Shares
Change 		Change in
Stake
Deutsche Bank
101
Deutsche Bank
Germany
$2.45M -$1.93M -32,359 -44%
CIS
102
Capital International Sarl
California
$2.27M -$2.18M -36,600 -49%
MSA
103
Mason Street Advisors
Wisconsin
$2.24M -$34.9K -585 -2%
AG
104
Advisor Group
Arizona
$2M +$3.4K +57 +0.2%
AAM
105
Azzad Asset Management
Virginia
$1.95M +$1.23M +20,582 +124%
SEC
106
Seven Eight Capital
New York
$1.95M +$1.7M +28,600 +738%
Nisa Investment Advisors
107
Nisa Investment Advisors
Missouri
$1.81M +$334K +5,610 +23%
First Trust Advisors
108
First Trust Advisors
Illinois
$1.81M -$10.8M -181,236 -86%
WB
109
WesBanco Bank
West Virginia
$1.79M – – –
SRAM
110
Stone Ridge Asset Management
New York
$1.79M +$310K +5,200 +21%
OPERF
111
Oregon Public Employees Retirement Fund
Oregon
$1.75M +$33.4K +561 +2%
MSL
112
Mackay Shields LLC
New York
$1.74M +$1.73M +28,961 New
T. Rowe Price Associates
113
T. Rowe Price Associates
Maryland
$1.61M +$14.1K +237 +0.9%
GAM
114
Gotham Asset Management
New York
$1.61M -$1.41M -23,590 -47%
MUAMU
115
Mitsubishi UFJ Asset Management (UK)
United Kingdom
$1.59M – – –
Pacer Advisors
116
Pacer Advisors
Pennsylvania
$1.57M -$120K -2,007 -7%
GIP
117
Granite Investment Partners
California
$1.38M +$51.6K +866 +4%
Federated Hermes
118
Federated Hermes
Pennsylvania
$1.34M -$105K -1,762 -7%
CC
119
Cipher Capital
New York
$1.32M +$1.31M +22,019 New
GC
120
Guggenheim Capital
Illinois
$1.29M -$206K -3,453 -14%
SOMRS
121
State of Michigan Retirement System
Michigan
$1.24M -$23.8K -400 -2%
CIC
122
Cornercap Investment Counsel
Georgia
$1.23M +$894 +15 +0.1%
NMIMC
123
Northwestern Mutual Investment Management Company
Wisconsin
$1.22M +$536 +9 +0%
MAM
124
Martingale Asset Management
Massachusetts
$1.22M -$41.5K -697 -3%
Asset Management One
125
Asset Management One
Japan
$1.21M -$269K -4,518 -18%
3 4
5
6 7

IART Hedge Fund Activity: Q3 2019 in Review

280 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q3 2019, worth a combined $4.16B — up 5.3% from $3.95B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new IART positions and 23 closed out — a net gain of 19 holders — while 100 added to existing stakes and 88 trimmed.

The largest buyer was Point72 Asset Management, adding an estimated $23.5M. The largest seller was Fidelity Investments, cutting an estimated $98.7M.

  • 280 institutional investors held Integra LifeSciences (IART) as of Q3 2019, up from 262 in Q2 2019.
  • Funds reported $4.16B of Integra LifeSciences stock for Q3 2019, up 5.3% quarter-over-quarter.
  • 42 funds opened new Integra LifeSciences positions in Q3 2019 and 23 closed out, a net change of +19 holders.
  • The largest Integra LifeSciences buyer in Q3 2019 was Point72 Asset Management, an estimated $23.5M added.
  • The largest Integra LifeSciences seller in Q3 2019 was Fidelity Investments, an estimated $98.7M sold.

Based on aggregated 13F filings for Q3 2019.